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Neural signalling: Does colocalization imply cotransmission?
Eve Marder
Recent results suggest that neurons that contain multiple
neurotransmitters may make synaptic connections with
different target neurons that are mediated by only a
subset of their transmitter complement.
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Today it is widely accepted that many, perhaps most,
neurons contain multiple signaling substances that can
function as neurotransmitters [1]. It is, however, far easier
to demonstrate the presence of multiple substances —
such as amino acids, amines, neuropeptides, ATP and so
on — within a neuron than it is to establish their physio-
logical roles, or indeed to show that they have any biologi-
cal activity at all [2]. It is not an accident that much of
what we know about the release of cotransmitters from
identified neurons has been discovered using peripheral
synapses of invertebrates and vertebrates [1,2], and that
we know relatively little about the control of cotransmit-
ter release from most central synapses.
Many neurons project to multiple postsynaptic sites, often
at quite large distances from each other. In extreme cases,
neurons may send projections to a number of different
brain regions or ganglia, and synapse onto several different
types of target neuron. In such cases, do neurons that
contain multiple transmitter substances release all of their
cotransmitters at all of their targets, or can they liberate
different subsets of their transmitter complement at differ-
ent synaptic endings? In some cases, it is clear that several
cotransmitters are liberated at the same terminals [1–3],
although it has been suggested that some neurons may seg-
regate different bioactive substances to different subsets of
their branches [4]. 
Figure 1 illustrates several possibilities that could occur
when a neuron produces multiple neurotransmitters. In
case 1, a neuron liberates the same mixture of neurotrans-
mitters at each of its endings, and all of its targets respond
to all of its cotransmitters. In case 2, the neuron again
liberates the same mixture of neurotransmitters at each of
its endings, but here the different target neurons have
receptors for different subsets of the cotransmitters, thereby
creating the situation in which the different synapses made
by the same neuron are mediated by different transmitter
substances. In case 3, the neuron liberates different sub-
stances from different presynaptic terminals, so that differ-
ent synapses evoked by the same neuron are mediated by
different neurotransmitters.  
A recent study by Blitz and Nusbaum [5] addressed this
issue in the case of the modulatory proctolin neuron (MPN)
of the stomatogastric nervous system of the crab Cancer bore-
alis [6,7]. The MPN has its soma in the oesophageal gan-
glion and projects to the paired commissural ganglia and to
the single stomatogastric ganglion (Figure 2). Immunocty-
ochemical studies showed that MPN contains the neu-
ropeptide proctolin [6,7] and the inhibitory neurotransmitter
γ-amino butyric acid (GABA) [8]. Previous work demon-
strated that the actions of the MPN in the stomatogastric
ganglion could be well-mimicked by proctolin [6,7]. But
Figure 1
Three cases describing the possible
postsynaptic actions of neurons that
produce multiple cotransmitters. In case 1,
the neuron has two different cotransmitters
— represented by the dark red and dark blue
synaptic vesicles — which are both liberated
from all of the presynaptic terminals of the
neuron, and all of the postsynaptic sites
contain receptors for both transmitters (light
red and light blue). In case 2, all of the
processes of the neuron release both
cotransmitters, but the target neurons have
receptors to just one of the two
cotransmitters. In case 3, different
processes of the neuron liberate different
cotransmitters, although the targets may
have receptors for both.
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on the basis of their new findings, Blitz and Nusbaum [5]
argue that the MPN liberates GABA, but not proctolin,
onto its targets in the commissural ganglia. 
The MPN inhibits two neurons of the commissural gan-
glion, MCN1 and CPN2 (Figure 2). Because both of these
neurons project to the crab’s stomatogastric ganglion, where
they activate the gastric mill rhythm [9,10], inhibition of
MCN1 and CPN2 by the MPN results in inhibition of the
gastric mill rhythm [11]. Blitz and Nusbaum [5] asked
whether the inhibitory actions of the MPN on MCN1 and
CPN2 could be mimicked by proctolin and/or GABA. 
When proctolin was applied to the commissural ganglia,
strong gastric mill rhythms were evoked, and MCN1 and
CPN2 were strongly activated. Moreover, when synaptic
transmission in the commissural ganglia was blocked by
placing them in low Ca2+/Mn2+-containing saline, proctolin
applications depolarized both MCN1 and CPN2. These
results argue that, although MCN1 and CPN2 have proc-
tolin receptors, they evoke an excitatory response, similar
to that evoked by proctolin on stomatogastric ganglion
neurons [12]. The application of GABA, in contrast, inhib-
ited both MCN1 and CPN2, and these GABA responses
persisted in low Ca2+/Mn2+ saline. Furthermore, the effects
of both GABA and the MPN on MCN1 and CPN2 could
be blocked by picrotoxin. 
Together, the data reported by Blitz and Nusbaum [5] are
consistent with the interpretation that MPN liberates
GABA, but not proctolin, from its terminals within the
commissural ganglia, but proctolin from its terminals in the
stomatogastric ganglion. These data suggest that, of the
various possibilities described above, case 3 (Figure 1) most
accurately accounts for the functional connections made by
MPN. What is still not known for this preparation, is
whether the terminals of MPN in the commissural ganglia
contain both proctolin and GABA — as do their somata in
the oesophageal ganglion — but only release GABA (at
least under the physiological conditions studied here), or
whether the different neurotransmitters are differentially
sorted into its different projections. Resolving this issue will
require immunocytochemical studies, at the electron micro-
scope level, on the MPN profiles in the neuropils of the
stomatogastric ganglion and commissural ganglia.
In the mid 1930s, Sir Henry Dale wrote one of the most
misquoted papers in the history of neuroscience [13]. Dale
knew that the neurotransmitter acetylcholine inhibited
some of its targets and excited others. For many years
‘Dale’s Law’ was that a neuron contains only one neuro-
transmitter that it releases from all of its terminals. In his
classic paper [13], Dale described the findings of the time
that, in cross-regeneration experiments, one kind of cholin-
ergic neuron could substitute for another, but adrenergic
postganglionic neurons could not substitute for cholinergic
neurons. It was observations of this kind that Dale was com-
menting on when he said “the nature of the chemical func-
tion, whether cholinergic or adrenergic, is characteristic for
each particular neurone, and unchangeable”. We now know
that neurons can release many different neurotransmitters,
and that the same neuron can evoke functionally different
postsynaptic responses on different targets. The paper by
Blitz and Nusbaum [5] argues that the somatic colocaliza-
tion of neurotransmitters does not imply functional cotrans-
mission at all of a neuron’s terminals. One imagines that
Dale would take great pleasure in seeing the rich functional
diversity possible with colocalization and cotransmission.
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Figure 2
The stomatogastric nervous system of the crab Cancer borealis,
showing the projections of the modulatory proctolin neuron (MPN, red)
and those of the commissural ganglion neuron CPN2. As discussed in
the text, the MPN releases GABA (green) in the commissural ganglion
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If you found this dispatch interesting, you might also want
to read the June 1999 issue of
Current Opinion in
Neurobiology
which included the following reviews, edited
by Mary B Kennedy and Mu-ming Poo, on
Signalling mechanisms :
The bacterial K+ channel structure and its implications
for neuronal channels
Gary Yellen 
Calcium channelopathies in the central nervous system
Joanna Jen 
Seizure disorders in mutant mice: relevance to 
human epilepsies
Ram S Puranam and James O McNamara
Regulation of back-propagating action potentials in
hippocampal neurons
Daniel Johnston, Dax A Hoffman, Costa M Colbert and
Jeffrey C Magee
Clearance of glutamate inside the synapse and beyond
Dwight E Bergles, Jeffrey S Diamond and Craig E Jahr
Roles of metabotropic glutamate receptors in LTP and
LTD in the hippocampus
Zuner A Bortolotto, Stephen M Fitzjohn and Graham L
Collingridge 
Calcium- and activity-dependent synaptic plasticity
Robert S Zucker
Optical detection of synaptic vesicle exocytosis 
and endocytosis
Venkatesh N Murthy
Synaptic vesicle docking and fusion
Sandra M Bajjalieh
Assembly of signaling machinery at the 
postsynaptic membrane
Joachim Kirsch
Brain protein serine/threonine phosphatases
Nancy E Price and Marc C Mumby
Structure, development, and plasticity of dendritic spines
Kristen M Harris
Effects of estrogen in the CNS
Catherine S Woolley
Signal transduction underlying growth cone guidance
by diffusible factors
Hong-jun Song and Mu-ming Poo
Axonal atrophy: the retraction reaction
Michael Bernstein and Jeff W Lichtman
The full text of Current Opinion in Neurobiology is in the
BioMedNet library at
http://BioMedNet.com/cbiology/nrb
